- Report
- April 2023
- 110 Pages
Global
From €4586EUR$4,750USD£3,883GBP
- Report
- January 2022
- 110 Pages
Global
From €4586EUR$4,750USD£3,883GBP
From €2510EUR$2,600USD£2,126GBP
- Report
- May 2021
- 50 Pages
China
From €2510EUR$2,600USD£2,126GBP
- Report
- September 2018
- 30 Pages
China
From €2124EUR$2,200USD£1,799GBP
- Report
- April 2021
- 47 Pages
Global
€21241EUR$22,000USD£17,987GBP
- Report
- July 2019
- 13 Pages
Global
€9655EUR$10,000USD£8,176GBP
- Report
- July 2019
- 14 Pages
Global
€9655EUR$10,000USD£8,176GBP
- Drug Pipelines
- June 2019
- 579 Pages
Global
€21241EUR$22,000USD£17,987GBP
- Report
- June 2019
- 15 Pages
Global
€9655EUR$10,000USD£8,176GBP
- Report
- June 2019
- 16 Pages
Global
€9655EUR$10,000USD£8,176GBP
- Report
- June 2019
- 14 Pages
Global
€9655EUR$10,000USD£8,176GBP
- Report
- June 2019
- 21 Pages
Global
€9655EUR$10,000USD£8,176GBP
- Report
- June 2019
- 15 Pages
Global
€9655EUR$10,000USD£8,176GBP
- Report
- June 2019
- 18 Pages
Global
€9655EUR$10,000USD£8,176GBP
- Report
- June 2019
- 14 Pages
Global
€9655EUR$10,000USD£8,176GBP
- Report
- June 2019
- 16 Pages
Global
€9655EUR$10,000USD£8,176GBP
- Report
- June 2019
- 14 Pages
Global
€9655EUR$10,000USD£8,176GBP
- Report
- November 2022
- 120 Pages
Africa
From €2414EUR$2,500USD£2,044GBP
- Report
- August 2022
Global
From €1149EUR$1,190USD£973GBP
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more